/XAR

XAR

XAR

$245.96USD↑+0.53%+1.30 today

MARKET CAP

0

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$244 – $248

52W RANGE

$215

$298

AI Summary

Stalk

Buy NowMedium

XAR remains in a Stage 2 corrective reset within a longer-term uptrend and has reclaimed its short-term EMAs and the 21 EMA/50 DMA support zone. Both long- and medium-term directional biases are bullish under repairing EMAs, and recent acceptance above the range pivot offers a buyable pullback. We recommend Buy Now on shallow retracements into the established support area near the 9/21 EMAs and 50 DMA. A decisive break below the 50 DMA with follow-through would invalidate this bullish view.

↑RSI exited oversold and MACD turned positive on Aug 3, supporting momentum.
↑XAR gained 7.34% over five days, indicating a bullish reversal.
↓Iran conflict heightens supply chain risks, threatening ETF performance.

Full analysis →

Buying

6

institutions

Selling

1

institutions

New Positions

0

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
JC Jpmorgan Chase & Co Q2 2026	BUY	178.97 K	49.57 M	+71.86 K	+91.1%	0.00%
CA Citadel Advisors LLC Q2 2026	BUY	58.77 K	16.68 M	+10.07 K	+34.8%	0.00%
RC Rockefeller Capital Management L.P. Q2 2026	BUY	40.67 K	11.54 M	+6.37 K	+32.5%	0.02%
RT Renaissance Technologies LLC Q2 2026	BUY	7.48 K	2.12 M	+5.88 K	+422.4%	0.00%
AC Aqr Capital Management LLC Q2 2026	BUY	4.95 K	1.40 M	+1.05 K	+48.6%	0.00%
BI Blackrock, Inc. Q2 2026	BUY	2.59 K	734.06 K	+776.00	+59.6%	0.00%
FA Fisher Asset Management, LLC Q2 2026	SELL	0.00	0.00	+-836.00	-100.0%	0.00%